Dr. Martens Publishes H1 FY27 Results Presentation Transcript
- Dr. Martens held its H1 FY27 results presentation on November 12, 2026, attended by CEO Ije Nwokorie and CFO Giles Wilson.
- Revenue fell 9.2% at constant currency to £292.4 million, with weakness concentrated in European direct-to-consumer sales.
- Adjusted EBIT swung to a reported £2.8 million loss from a £3.1 million profit a year earlier.
- Boots revenue dropped 20%, exacerbated by historically hot weather; management cited continued pressure on core black smooth styles.
- Gross margin rose 80 basis points to 65.4% on a comparable basis, supported by pricing discipline and lower costs.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Martens plc published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.